Literature DB >> 33293703

SGLT2 inhibitors in people with and without T2DM.

Kamlesh Khunti1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33293703     DOI: 10.1038/s41574-020-00453-2

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN: 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  7 in total

1.  Empagliflozin Improves Insulin Sensitivity of the Hypothalamus in Humans With Prediabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Trial.

Authors:  Stephanie Kullmann; Julia Hummel; Robert Wagner; Corinna Dannecker; Andreas Vosseler; Louise Fritsche; Ralf Veit; Konstantinos Kantartzis; Jürgen Machann; Andreas L Birkenfeld; Norbert Stefan; Hans-Ulrich Häring; Andreas Peter; Hubert Preissl; Andreas Fritsche; Martin Heni
Journal:  Diabetes Care       Date:  2022-02-01       Impact factor: 19.112

Review 2.  Emerging roles of Sodium-glucose cotransporter 2 inhibitors in Diabetic kidney disease.

Authors:  Tian Gan; Yi Song; Feng Guo; Guijun Qin
Journal:  Mol Biol Rep       Date:  2022-08-24       Impact factor: 2.742

Review 3.  Impact of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors on Arterial Stiffness and Vascular Aging-What Do We Know So Far? (A Narrative Review).

Authors:  Cristina Andreea Adam; Razvan Anghel; Dragos Traian Marius Marcu; Ovidiu Mitu; Mihai Roca; Florin Mitu
Journal:  Life (Basel)       Date:  2022-05-27

Review 4.  Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care.

Authors:  Hyon K Choi; Natalie McCormick; Chio Yokose
Journal:  Nat Rev Rheumatol       Date:  2021-12-17       Impact factor: 32.286

5.  Long COVID - metabolic risk factors and novel therapeutic management.

Authors:  Kamlesh Khunti; Melanie J Davies; Mikhail N Kosiborod; Michael A Nauck
Journal:  Nat Rev Endocrinol       Date:  2021-07       Impact factor: 43.330

6.  SGLT2 inhibition restrains thyroid cancer growth via G1/S phase transition arrest and apoptosis mediated by DNA damage response signaling pathways.

Authors:  Yan Wang; Longyan Yang; Lin Mao; Lijie Zhang; Yingjun Zhu; Yongsong Xu; Yanan Cheng; Rongxin Sun; Yuanyuan Zhang; Jing Ke; Dong Zhao
Journal:  Cancer Cell Int       Date:  2022-02-11       Impact factor: 5.722

Review 7.  Carbohydrate-based drugs launched during 2000-2021.

Authors:  Xin Cao; Xiaojing Du; Heng Jiao; Quanlin An; Ruoxue Chen; Pengfei Fang; Jing Wang; Biao Yu
Journal:  Acta Pharm Sin B       Date:  2022-05-23       Impact factor: 14.903

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.